Loading... Please wait... Loading... Please wait...
ESTIMATED
11/10/2022
11/10/2022
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Fresh Tracks Therapeutics, Inc. last posted its earnings results on Thursday, November 10th, 2022. The company reported $-2.07 earnings per share for the quarter, missing analysts' consensus estimates of $-1.89 by $0.18. The company had revenue of 0 for the quarter and had revenue of 8.01 M for the year. Fresh Tracks Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.96 diluted earnings per share) and currently has a price-to-earnings ratio of -1. Fresh Tracks Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 3rd, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 12/30/2023 | Q4 2023 | -$0.21 | $6.00 M | $0 | 11/13/2023 | Q3 2023 | $0.32 | $7.94 M | 08/11/2023 | Q2 2023 | -$0.39 | $53,000 | 05/10/2023 | Q1 2023 | -$1.12 | $9,000 | 03/30/2023 | Q4 2022 | -$1.38 | $2.05 M | $2.05 M | 11/10/2022 | Q3 2022 | -$2.05 | $486,000 | 08/11/2022 | Q2 2022 | -$0.31 | $4.32 M | 05/12/2022 | Q1 2022 | -$2.59 | -$3.55 | -0.96 | $92,000 | 03/15/2022 | Q4 2021 | -$3.82 | -$2.53 | 1.29 | $104,000 | 11/09/2021 | Q3 2021 | -$5.62 | -$7.15 | -1.53 | $132,000 | 08/12/2021 | Q2 2021 | -$5.62 | -$7.29 | -1.67 | $151,000 | 05/13/2021 | Q1 2021 | -$5.17 | -$6.63 | -1.46 | $17,000 | 03/09/2021 | Q4 2020 | -$4.05 | -$6.84 | -2.79 | $27,000 | 11/12/2020 | Q3 2020 | -$8.32 | -$6.93 | 1.39 | $142,000 | 08/12/2020 | Q2 2020 | -$19.49 | $607,000 | 05/13/2020 | Q1 2020 | -$20.28 | $1.05 M | 03/18/2020 | Q4 2019 | -$61.94 | $669,000 | 11/13/2019 | Q3 2019 | -$73.08 | $1.18 M | 07/12/2019 | Q2 2019 | -$34.65 | -$33.54 | 1.11 | $0 | 05/02/2019 | Q1 2019 | -$56.70 | -$349.79 | -293.09 | $0 |
|---|
A. Fresh Tracks Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 3rd, 2024 based off last year's report dates.
A. The conference call for Fresh Tracks Therapeutics, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Fresh Tracks Therapeutics, Inc.'s latest earnings report can be read online.
A. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) has a recorded annual revenue of $8.01 M.
A. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) has a recorded net income of $8.01 M. Fresh Tracks Therapeutics, Inc. has generated $-0.96 earnings per share over the last four quarters.
A. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) has a price-to-earnings ratio of -1 and price/earnings-to-growth ratio is -0.01.
